Dr. Philip James Hanwright, MD

Dr. Hanwright practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Hanwright's NPI, 1033509997, was assigned on January 30, 2015. Dr. Hanwright graduated from Feinberg School of Medicine in 2015. Dr. Hanwright holds Texas license T4379.

Dr. Hanwright's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Hanwright's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanwright practices. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Hanwright's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Hanwright is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Hanwright's licenses on file in 3 states: Texas, Maryland and Pennsylvania.

Dmand AI lists breast reconstruction among the conditions Dr. Hanwright treats.

CMS data shows 37 Medicare services from Dr. Hanwright across 2 procedure codes in 2024, all of them office visits, for 46 Medicare patients. Medicare paid $4,517 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 46 Medicare patients who saw Dr. Hanwright in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hanwright's median patient age at 66, with 94% women.

In 2024, Dr. Hanwright wrote 28 Medicare Part D claims for 17 patients. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $69 in total drug cost. In 2016, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Hanwright for performance year 2024, reported as part of a group. Dr. Hanwright accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hanwright as offering telehealth. CMS counts 18 procedures of mastectomy by Dr. Hanwright, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Hanwright, published from 2011 to 2025. 2013 was the busiest year, with 6. The most frequent topics are Postoperative Complications, Body Mass Index and Mammaplasty. Dr. Hanwright has published most often in Plast Reconstr Surg. Dr. Hanwright's most frequent co-authors are Neil Fine, MD, Karl Y. Bilimoria, MD and Ian Chow, MD.

CMS Open Payments shows 76 general payments to Dr. Hanwright from 19 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Allergan Inc. paid the most, $1,033.

Dmand AI lists 1 award for Dr. Hanwright.

Dr. Hanwright graduated from Feinberg School of Medicine in 2015.

Dr. Hanwright is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.